WatchGuard establishes office in Noida, India to expand R&D operations
Category: #business  By Mateen Dalal  Date: 2019-03-28
  • share
  • Twitter
  • Facebook
  • LinkedIn

WatchGuard establishes office in Noida, India to expand R&D operations
  • This office signifies the latest investment from the company into its aggressive IT Development initiatives
     
  • An important focus for its team would be for driving the R&D for new WatchGuard Cloud platform features

WatchGuard Technologies has recently announced the opening of a new office in Noida, India. This new office signifies the latest investment from the company into its aggressive IT Development and R&D initiatives, along with its focus on designing and developing main features in the WatchGuard Cloud platform.

A news release by WatchGuard reveals that, Awanti Singh, an information security industry veteran, is leading the development initiative as well as the rapid growth targets of the office. Singh stated that this is an exciting time for being at this firm for those who are eager towards building a cutting-edge technology, as the firm keeps on redefining the security market and transforming the network security industry.

Singh added that the most important focus for its team would be driving the R&D for new WatchGuard Cloud platform features, along with providing IT Development for its key product initiatives, which would enable the firm in continuing its rapid pace in terms of product innovation.

Chief Executive Officer of WatchGuard, Prakash Panjwani, said in a statement that the unrelenting commitment of the company towards product innovation heavily relies on the growing R&D capabilities of its global engineering team.

Panjwani further said that the company believes its people are the most important asset of this company and the massive experience of leadership and engineering Awanti brings to the table, and the enormously gifted team she has been building in India, would be instrumental in the ongoing development of WatchGuard Cloud.

It will also help to provide accelerated momentum and growth in 2019 and beyond for the company, Panjwani mentioned.

The new location, which is purportedly the first office of WatchGuard in India, enhances the ever-expanding global presence of the company and was strategically selected owing to the business environment and culture, the abundance of skilled engineering talent, along with the existing relationships of WatchGuard in the region.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
By Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
By Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

AbbVie buys Mavupharma to target STING pathway for cancer treatment
AbbVie buys Mavupharma to target STING pathway for cancer treatment
By Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...